Bone mineral density and markers of bone turnover in boys with constitutional delay of growth and puberty
- PMID: 15687323
- DOI: 10.1210/jc.2005-0086
Bone mineral density and markers of bone turnover in boys with constitutional delay of growth and puberty
Abstract
It has been suggested that poor growth in childhood or puberty might be a correctable determinant of osteoporosis. To assess the effect of the growth and puberty delay on bone metabolism, we measured bone mineral density (BMD) and markers of bone turnover in 41 boys with constitutional delay of growth and puberty. Total body (TB) and lumbar spine (LS) BMD were measured by dual-energy x-ray absorptiometry. Serum osteocalcin, total alkaline phosphatase, and urinary deoxypyridinoline cross-links as markers of bone turnover were evaluated. BMD was decreased by at least 1 sd in TB in 23 boys (56%) and in LS in 27 boys (66%). After adjustment of BMD for bone age, TB was decreased in 11 boys (27%) and LS in 13 boys (32%). Bone age and chronological age significantly correlated with areal and volumetric BMD. The significant increments of height, weight, TB, and LS BMD between the consecutive pubertal stages were reported. Mean alkaline phosphatase, osteocalcin, and deoxypyridinoline were within reference ranges and showed no differences between pubertal stages. In conclusion, in boys with constitutional delay of growth and puberty, bone turnover is normal, and BMD increases in a manner similar to healthy children.
Similar articles
-
[Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].Ann Acad Med Stetin. 2000;46:165-76. Ann Acad Med Stetin. 2000. PMID: 11712302 Clinical Trial. Polish.
-
[Selected markers of bone metabolism in boys with constitutional delay of growth and puberty].Przegl Lek. 2000;57(2):87-92. Przegl Lek. 2000. PMID: 10907349 Clinical Trial. Polish.
-
Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters.J Bone Miner Metab. 2005;23(6):476-82. doi: 10.1007/s00774-005-0631-6. J Bone Miner Metab. 2005. PMID: 16261455
-
Sex steroids and the acquisition of bone mass.Horm Res. 1997;48 Suppl 5:65-71. doi: 10.1159/000191331. Horm Res. 1997. PMID: 9434047 Review.
-
Androgen replacement in children with constitutional delay of puberty: the case for aggressive therapy.Baillieres Clin Endocrinol Metab. 1998 Oct;12(3):427-40. doi: 10.1016/s0950-351x(98)80172-9. Baillieres Clin Endocrinol Metab. 1998. PMID: 10332564 Review.
Cited by
-
IGF-1 and insulin receptors in LepRb neurons jointly regulate body growth, bone mass, reproduction, and metabolism.bioRxiv [Preprint]. 2024 Sep 20:2024.09.20.614140. doi: 10.1101/2024.09.20.614140. bioRxiv. 2024. PMID: 39345425 Free PMC article. Preprint.
-
Transition of young adults with metabolic bone diseases to adult care.Front Endocrinol (Lausanne). 2023 Mar 17;14:1137976. doi: 10.3389/fendo.2023.1137976. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37008909 Free PMC article. Review.
-
Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy.Cells. 2019 Oct 25;8(11):1318. doi: 10.3390/cells8111318. Cells. 2019. PMID: 31731497 Free PMC article. Review.
-
Broad application prospects of bone turnover markers in pediatrics.J Clin Lab Anal. 2022 Sep;36(9):e24656. doi: 10.1002/jcla.24656. Epub 2022 Aug 10. J Clin Lab Anal. 2022. PMID: 35949006 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical